Editor’s Note
Hugel has officially entered India’s botulinum toxin market, targeting a 9% share this year amid rising K-beauty interest among the country’s growing middle class.
Reporter Hong Da-young | Input 2026.07.22. 17:52 | Updated 2026.07.22. 17:59
Hugel announced its entry into the Indian botulinum toxin (Botox) market on the 22nd. India, with a population of 1.5 billion, has a growing interest in K-beauty among its middle class. Hugel aims to achieve a 9% market share in India this year.
Hugel recently participated in the Global Aesthetic Summit held in India, showcasing its Botox product, Letibo. Botox is derived from toxic proteins extracted from Clostridium botulinum bacteria. When injected into the skin, it temporarily paralyzes muscles, smoothing fine wrinkles.
![[단독] ‘여권 구세주’ 이광범 LKB평산 대표변호사, 농협중앙회 사외이사 선임](https://img.lashnews.com/lashnews/news-body/2026/07/hugel-enters-india-s-botox-market-chosun-biz-3-672a2fd5f848.avif)
Hugel, in partnership with its local distributor Aka Medical, is conducting product events until the 24th. Academic exchanges and workshops are also being prepared. Hugel plans to accelerate its expansion into the Asia-Pacific region, using India as a base.
